Spanish researchers belonging to the Spanish Lung Cancer Group (GECP) have confirmed that cancer patients have a higher risk of suffering from COVID-19 in a serious way than the general population. Thus, this research group has analyzed in its GRAVID study a total of 447 cases of lung cancer patients diagnosed with coronavirus during the first...
Cancer drugs capable of weakening the body's immune defenses are no more likely to increase the risk of infection or death from Covid-19 than breast cancer therapies that do not undermine the immune system, according to a new study published in the journal 'JCO Global Oncology'. Researchers say the results challenge initial concerns that such tr...
A new medicinal technology developed in Switzerland harnesses a modified virus for the production and transport of various anti-tumor therapy agents within human tissue affected by cancer. The antibodies, cytokines and other signaling substances required for treatment in this case are produced by the cancer cells themselves and destroy the tumor...
